China Crackdown on corruption in health : Opportunities for International Pharma Firms
China has embarked on a monumental anti-corruption crusade, aiming its crosshairs at the healthcare behemoth that is its hospitals, pharmaceutical realm, and insurance funds. The motives are manifold – a slowing economy, public discontent due to astronomical healthcare costs, and the overarching need to foster a cleaner, transparent healthcare ecosystem. To quantify, over 180 hospital…